Literature DB >> 16541121

Adenovirus serotype 35 vector-mediated transduction into human CD46-transgenic mice.

F Sakurai1, K Kawabata, N Koizumi, N Inoue, M Okabe, T Yamaguchi, T Hayakawa, H Mizuguchi.   

Abstract

We previously demonstrated that systemic administration of adenovirus serotype 35 (Ad35) vectors to mice does not mediate efficient transduction in organs, probably because expression of the mouse analog of the subgroup B Ad receptor, human CD46 (membrane cofactor protein), is limited to the testis. Here, we describe the in vitro and in vivo transduction characteristics of Ad35 vectors by using homozygous and hemizygous human CD46-transgenic (CD46TG) mice, which ubiquitously express human CD46. An Ad35 vector more efficiently transduced the primary dendritic cells and macrophages prepared from CD46TG mice than those from wild-type mice. In vivo transduction experiments demonstrated that CD46TG mice are more susceptible to Ad35 vector-mediated in vivo transduction than are wild-type mice. In particular, homozygous CD46TG mice, which express higher levels of CD46 in the organs than hemizygous CD46TG mice, tend to exhibit higher transduction efficiencies after intraperitoneal administration than hemizygous CD46TG mice. Intraperitoneal administration of Ad35 vectors resulted in efficient transduction into the mesothelial cells of the peritoneal organs in homozygous CD46TG mice. These results indicate that an Ad35 vector recognizes human CD46 as a cellular receptor in CD46TG mice. However, the in vivo transduction efficiencies of Ad35 vectors in CD46TG mice are much lower than those of conventional Ad5 vectors in wild-type mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16541121     DOI: 10.1038/sj.gt.3302749

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  11 in total

Review 1.  Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS.

Authors:  Seung T Lim; Mikko Airavaara; Brandon K Harvey
Journal:  Pharmacol Res       Date:  2009-10-17       Impact factor: 7.658

Review 2.  In Vivo Hematopoietic Stem Cell Transduction.

Authors:  Maximilian Richter; Daniel Stone; Carol Miao; Olivier Humbert; Hans-Peter Kiem; Thalia Papayannopoulou; André Lieber
Journal:  Hematol Oncol Clin North Am       Date:  2017-10       Impact factor: 3.722

3.  In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors.

Authors:  Maximilian Richter; Kamola Saydaminova; Roma Yumul; Rohini Krishnan; Jing Liu; Eniko-Eva Nagy; Manvendra Singh; Zsuzsanna Izsvák; Roberto Cattaneo; Wolfgang Uckert; Donna Palmer; Philip Ng; Kevin G Haworth; Hans-Peter Kiem; Anja Ehrhardt; Thalia Papayannopoulou; André Lieber
Journal:  Blood       Date:  2016-08-23       Impact factor: 22.113

4.  GammadeltaT cells initiate acute inflammation and injury in adenovirus-infected liver via cytokine-chemokine cross talk.

Authors:  Maureen N Ajuebor; Yijun Jin; Griffin L Gremillion; Robert M Strieter; Qingling Chen; Patrick A Adegboyega
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

5.  Influence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectors.

Authors:  Jenny A Greig; Suzanne Mk Buckley; Simon N Waddington; Alan L Parker; David Bhella; Rebecca Pink; Ahad A Rahim; Takashi Morita; Stuart A Nicklin; John H McVey; Andrew H Baker
Journal:  Mol Ther       Date:  2009-07-14       Impact factor: 11.454

6.  Characterization of human adenovirus serotypes 5, 6, 11, and 35 as anticancer agents.

Authors:  Elena V Shashkova; Shannon M May; Michael A Barry
Journal:  Virology       Date:  2009-09-18       Impact factor: 3.616

7.  Epithelial Junction Opener Improves Oncolytic Adenovirus Therapy in Mouse Tumor Models.

Authors:  Roma Yumul; Maximilian Richter; Zhuo-Zhuang Lu; Kamola Saydaminova; Hongjie Wang; Chung-Huei Katherine Wang; Darrick Carter; André Lieber
Journal:  Hum Gene Ther       Date:  2016-04       Impact factor: 5.695

8.  Adenovirus vectors targeting distinct cell types in the retina.

Authors:  J Harry Sweigard; Siobhan M Cashman; Rajendra Kumar-Singh
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-05       Impact factor: 4.799

9.  Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells).

Authors:  Joanna L Howarth; Youn Bok Lee; James B Uney
Journal:  Cell Biol Toxicol       Date:  2009-10-15       Impact factor: 6.691

Review 10.  Adenovirus receptors and their implications in gene delivery.

Authors:  Anurag Sharma; Xiaoxin Li; Dinesh S Bangari; Suresh K Mittal
Journal:  Virus Res       Date:  2009-02-26       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.